United States Pharmaceuticals

Novan Inc (NOVN)

Track

Ticker: NOVN Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Novan Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
SANDERS MACHELLE
1 sale — total 4,716 USD
Sale 27 Jun 2023
Value US$4,263,676.78 | Price 73.82 | Shares 82,653
Proposed sale 9 Jun 2023
Value US$2,459,289.67 | Price 460.44 | Shares 37,844
Buy 7 Apr 2022
Value US$3,448.80 | Price 3.45 | Shares 1,000
Buy 28 Mar 2022
Value US$3,450.00 | Price 3.45 | Shares 1,000
Buy 25 Mar 2022
Value US$7,090.00 | Price 3.55 | Shares 2,000
Buy 18 Mar 2022
Value US$3,500.00 | Price 3.50 | Shares 1,000
Buy 18 Mar 2022
Value US$36,350.00 | Price 3.64 | Shares 10,000
Buy 17 Mar 2022
Value US$16,705.00 | Price 3.34 | Shares 5,000
Buy 16 Mar 2022
Value US$16,685.00 | Price 3.34 | Shares 5,000
Buy 26 Mar 2021
Value US$100,100.00 | Price 1.43 | Shares 70,000
Buy 3 Mar 2020
Value US$0.00 | Price 0.00 | Shares 200,000
Buy 3 Mar 2020
Value US$0.00 | Price 0.00 | Shares 7,000
Sale 2 Jul 2019
Value US$17,289.25 | Price 2.75 | Shares 6,287
Sale 1 Jul 2019
Value US$2,501.62 | Price 2.74 | Shares 913
Sale 28 Jun 2019
Value US$47,882.00 | Price 2.69 | Shares 17,800
Buy 29 May 2019
Value US$2,955.00 | Price 1.97 | Shares 1,500
Buy 28 May 2019
Value US$7,525.00 | Price 2.15 | Shares 3,500
Buy 24 May 2019
Value US$44,000.00 | Price 2.20 | Shares 20,000
Buy 22 May 2019
Value US$110,500.00 | Price 2.21 | Shares 50,000
Buy 21 May 2019
Value US$9,500.00 | Price 1.90 | Shares 5,000
Buy 20 May 2019
Value US$153,600.00 | Price 1.92 | Shares 80,000
Buy 17 May 2019
Value US$57,200.00 | Price 1.43 | Shares 40,000
Buy 17 May 2019
Value US$28,600.00 | Price 1.43 | Shares 20,000
Buy 17 May 2019
Value US$22,350.00 | Price 1.50 | Shares 14,900
Buy 17 May 2019
Value US$7,938.00 | Price 1.47 | Shares 5,400
Buy 17 May 2019
Value US$1,032.57 | Price 1.49 | Shares 693
Buy 28 Sep 2018
Value US$142,000.00 | Price 2.84 | Shares 50,000
Buy 26 Sep 2018
Value US$27,300.00 | Price 2.73 | Shares 10,000
Buy 22 Aug 2018
Value US$53,200.00 | Price 2.66 | Shares 20,000
Buy 21 Aug 2018
Value US$81,300.00 | Price 2.71 | Shares 30,000
Buy 29 Aug 2017
Value US$39,785.50 | Price 4.70 | Shares 8,465
Buy 25 Aug 2017
Value US$15,023.75 | Price 4.25 | Shares 3,535
Buy 23 Aug 2017
Value US$47,880.00 | Price 3.99 | Shares 12,000
Buy 26 Sep 2016
Value US$8,800,000.00 | Price 11.00 | Shares 800,000
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2023-06-27 2023-06-27 S Sale
2.2
SANDERS MACHELLE
Non-Executive Director
82,653 +3.4%
73.82
US$4,263,677 		82,653 +3.4% 73.82 US$4,263,677
2023-06-09 2023-06-09 PrS Proposed sale
3.6
GAY JOHN M.

Officer

Officer
37,844
460.44
US$2,459,290 		37,844 460.44 US$2,459,290
2022-04-11 2022-04-07 B Purchase
1.0
BIERMAN JAMES L
Non-Executive Director
73,971 +9.2%
388.38
US$108,195 		73,971 +9.2% 388.38 US$108,195
2022-03-30 2022-03-28 B Purchase
1.0
BIERMAN JAMES L
Non-Executive Director
1,000 +50.0%
3.45
US$3,450 		1,000 +50.0% 3.45 US$3,450
2022-03-28 2022-03-25 B Purchase
1.0
BIERMAN JAMES L
Non-Executive Director
2,000 +inf%
3.55
US$7,090 		2,000 +inf% 3.55 US$7,090
2022-03-22 2022-03-18 B Purchase
3.6
GAY JOHN M.

Chief Financial Officer

Officer
1,000 +66.7%
3.50
US$3,500 		1,000 +66.7% 3.50 US$3,500
2022-03-22 2022-03-18 B Purchase
2.8
PALMOUR JOHN W
Non-Executive Director
10,000 +16.8%
3.64
US$36,350 		10,000 +16.8% 3.64 US$36,350
2022-03-18 2022-03-17 B Purchase
2.8
PALMOUR JOHN W
Non-Executive Director
5,000 +9.2%
3.34
US$16,705 		5,000 +9.2% 3.34 US$16,705
2022-03-18 2022-03-16 B Purchase
2.8
PALMOUR JOHN W
Non-Executive Director
5,000 +10.1%
3.34
US$16,685 		5,000 +10.1% 3.34 US$16,685
2021-03-29 2021-03-26 B Purchase
3.1
STAFFORD PAULA B

President and CEO

Executive Director
70,000 +86.7%
1.43
US$100,100 		70,000 +86.7% 1.43 US$100,100
2020-03-05 2020-03-03 B Purchase
2.8
PALMOUR JOHN W
Non-Executive Director
200,000
0.00
US$0 		200,000 0.00 US$0
2020-03-05 2020-03-03 B Purchase
2.2
SANDERS MACHELLE
Non-Executive Director
7,000
0.00
US$0 		7,000 0.00 US$0
2019-07-02 2019-07-02 S Sale
3.3
Malin Life Sciences Holdings Ltd
Large shareholder
6,287 -0.2%
2.75
US$17,289 		6,287 -0.2% 2.75 US$17,289
2019-07-02 2019-07-01 S Sale
3.3
Malin Life Sciences Holdings Ltd
Large shareholder
913 -0.0%
2.74
US$2,502 		913 -0.0% 2.74 US$2,502
2019-07-02 2019-06-28 S Sale
3.3
Malin Life Sciences Holdings Ltd
Large shareholder
17,800 -0.7%
2.69
US$47,882 		17,800 -0.7% 2.69 US$47,882
2019-05-30 2019-05-29 B Purchase
3.7
Martin G. Kelly

Chief Executive Officer

Executive Director
1,500 +3.4%
1.97
US$2,955 		1,500 +3.4% 1.97 US$2,955
2019-05-29 2019-05-28 B Purchase
3.7
Martin G. Kelly

Chief Executive Officer

Executive Director
3,500 +8.8%
2.15
US$7,525 		3,500 +8.8% 2.15 US$7,525
2019-05-29 2019-05-24 B Purchase
2.8
PALMOUR JOHN W
Non-Executive Director
20,000 +7.3%
2.20
US$44,000 		20,000 +7.3% 2.20 US$44,000
2019-05-23 2019-05-22 B Purchase
3.1
INGRAM ROBERT ALEXANDER
Non-Executive Director
50,000 +41.7%
2.21
US$110,500 		50,000 +41.7% 2.21 US$110,500
2019-05-23 2019-05-21 B Purchase
3.3
Geer W Kent
5,000 +46.2%
1.90
US$9,500 		5,000 +46.2% 1.90 US$9,500
2019-05-21 2019-05-20 B Purchase
3.1
STAFFORD PAULA B

President and COO

Executive Director
80,000 +11544.0%
1.92
US$153,600 		80,000 +11544.0% 1.92 US$153,600
2019-05-21 2019-05-17 B Purchase
3.7
Martin G. Kelly

Chief Executive Officer

Executive Director
40,000 +inf%
1.43
US$57,200 		40,000 +inf% 1.43 US$57,200
2019-05-21 2019-05-17 B Purchase
3.7
Martin G. Kelly

Chief Executive Officer

Executive Director
20,000 +50.0%
1.43
US$28,600 		20,000 +50.0% 1.43 US$28,600
2019-05-21 2019-05-17 B Purchase
3.6
GAY JOHN M.

VP, Finance & Corp. Controller
14,900 +14900.0%
1.50
US$22,350 		14,900 +14900.0% 1.50 US$22,350
2019-05-21 2019-05-17 B Purchase
3.4
NOVAK ANDREW

VP, Accounting and Bus Ops
5,400 +415.4%
1.47
US$7,938 		5,400 +415.4% 1.47 US$7,938
2019-05-21 2019-05-17 B Purchase
3.1
STAFFORD PAULA B

President and COO

Executive Director
693 +inf%
1.49
US$1,033 		693 +inf% 1.49 US$1,033
2018-10-01 2018-09-28 B Purchase INGRAM ROBERT ALEXANDER Non-Executive Director
50,000 +71.7%
2.84
US$142,000 		50,000 +71.7% 2.84 US$142,000
2018-09-27 2018-09-26 B Purchase Martin G. Kelly

Chief Executive Officer

Executive Director
10,000 +33.3%
2.73
US$27,300 		10,000 +33.3% 2.73 US$27,300
2018-08-24 2018-08-22 B Purchase
2.8
PALMOUR JOHN W
Non-Executive Director
20,000 +7.9%
2.66
US$53,200 		20,000 +7.9% 2.66 US$53,200
2018-08-23 2018-08-21 B Purchase Martin G. Kelly

Chief Executive Officer

Executive Director
30,000 +inf%
2.71
US$81,300 		30,000 +inf% 2.71 US$81,300
2017-08-29 2017-08-29 B Purchase INGRAM ROBERT ALEXANDER
8,465 +13.8%
4.70
US$39,786 		8,465 +13.8% 4.70 US$39,786
2017-08-29 2017-08-25 B Purchase INGRAM ROBERT ALEXANDER
3,535 +6.1%
4.25
US$15,024 		3,535 +6.1% 4.25 US$15,024
2017-08-25 2017-08-23 B Purchase
2.8
PALMOUR JOHN W
12,000 +5.0%
3.99
US$47,880 		12,000 +5.0% 3.99 US$47,880
2016-09-28 2016-09-26 B Purchase Malin Life Sciences Holdings Ltd Large shareholder
800,000 +43.9%
11.00
US$8,800,000 		800,000 +43.9% 11.00 US$8,800,000
Explore more

More insider trading research around Novan Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America